Effect of Boceprevir On Red Blood Cells and Markers of Anaemia in Healthy Volunteers

Trial Profile

Effect of Boceprevir On Red Blood Cells and Markers of Anaemia in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 18 May 2011

At a glance

  • Drugs Boceprevir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Merck & Co
  • Most Recent Events

    • 18 May 2011 New trial record
    • 10 May 2011 Results presented at the Digestive Disease Week 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top